【Bora Pharma】February 2026 Revenue: NT$1.326 Billion (YoY -23.2%)
Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2% decrease year-over-year. As a company specializing in pharmaceutical CDMO within the biotech and healthcare industry, this financial performance reflects the cyclical fluctuations of the sector.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Ticker: 6472
Company Name: Bora
Industry: Biotechnology & Medical Care
Data for: 2026-02
Monthly Revenue: 1,326,086 thousand NTD (1.326 billion)
Year-over-Year Change: -23.2%
Company Name: Bora
Industry: Biotechnology & Medical Care
Data for: 2026-02
Monthly Revenue: 1,326,086 thousand NTD (1.326 billion)
Year-over-Year Change: -23.2%